Block of purinergic P2X7R inhibits tumor growth in a c6 glioma brain tumor animal model

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 1, 2011, Pages 13-22

  Ryu, Jae K ^a   Jantaratnotai, Nattinee ^b   Serrano Perez, Maria C ^c   McGeer, Patrick L ^a   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Mahidol University   (Thailand)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Astrocytes; Brilliant blue G; Glioma tumor model; Microglia; Purinergic P2X7R

Indexed keywords

BRILLIANT BLUE G; LIGAND; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; COOMASSIE BRILLIANT BLUE; FUCHSINE; GROWTH INHIBITOR; PURINERGIC P2X RECEPTOR ANTAGONIST;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN TUMOR; CANCER INHIBITION; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL CULTURE;

AGED; ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; GLIOMA; GROWTH INHIBITORS; HUMANS; MALE; MIDDLE AGED; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X7; ROSANILINE DYES; TUMOR CELLS, CULTURED;

EID: 78650677507     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318201d4d4     Document Type: Article

References (36)

1. Matute C, Torre I, Perez-Cerda F, et al. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 2007;27:9525-33
2. Parvathenani LK, Tertyshnikova S, Greco CR, et al. P2X7 mediates superoxide production in primary microglia and is upregulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 2003;278: 13309-17
3. Ryu JK, McLarnon JG. Block of purinergic P2X7 receptor is neuro-protective in an animal model of Alzheimer's disease. Neuroreport 2008; 19:1715-19
4. Franke H, Gunther A, Grosche J, et al. P2X7 expression after ischemia in cerebral cortex of rats. J Neuropathol Exp Neurol 2004;63:686-99
5. Peng W, Cotrina ML, Han X, et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 2009;106:12489-93
6. 1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain. Curr Alzheimer Res 2008;5:475-80
7. Wang X, Arcuino G, Takano T, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004;10:821-27
8. McLarnon JG, Ryu JK, Walker DG, et al. Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-AYtreated microglia and in peptide-injected rat hippocampus. J Neuropathol Exp Neurol 2006;65:1090-97
9. Wei W, Ryu JK, Choi HB, et al. Expression and function of the P2X7 receptor in rat C6 glioma cells. Cancer Lett 2008;260:79-87
10. Streit WJ. Cellular immune response in brain tumors. Neuropathol Appl Neurobiol 1994;20:205-6
11. Roggendorf W, Strupp S, Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 1996; 92:288-93
12. Huettner C, Czub S, Kerkau S, et al. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 1997;17:3217-24
13. Badie B, Schartner JM, Hagar AR, et al. Microglia cyclooxygenase-2 activity in experimental gliomas: Possible role in cerebral edema formation. Clin Cancer Res 2003;9:872-77
14. Watters JJ, Schartner JM, Badie B. Microglia function in brain tumors. J Neurosci Res 2005;81:447-55
15. Galarneau H, Villeneuve J, Gowing G, et al. Increased glioma growth in mice depleted of macrophages. Cancer Res 2007;67:8874-81
16. Zhang L, Alizadeh D, Van Handel M, et al. Stat 3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia 2009;57: 1458-67
17. Kaur G, Han SJ, Yang I, et al. Microglia and central nervous system immunity. Neurosurg Clin N Am 2010;21:43-51
18. Jantaratnotai N, Choi HB, McLarnon JG. ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells. BMC Cancer 2009;9:442
19. Galasso JM, Stegman LD, Blaivas M, et al. Experimental gliosarcoma induces chemokine receptor expression in rat brain. Exp Neurol 2000; 161:85-95
20. Kielian T, van Rooijen N, Hickey WF. MCP-1 expression in CNS-1 astrocytoma cells: Implications for macrophage infiltration into tumors in vivo. J Neurooncol 2002;56:1-12
21. Ryu JK, Cho T, Choi HB, et al. Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology. J Neurosci 2009;29:3-13
22. Ryu JK, McLarnon JG. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuro-protective against acute excitotoxic striatal insult. J Neuroinflamm 2008; 5:18
23. Ryu JK, Jantararnotai N, McLarnon JG. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum. Neuroscience 2009;163:601-8
24. Jiang LH, Mackenzie AB, North RA, et al. Brilliant blue G selectively blocks ATP-gated P2X7 receptors. Mol Pharmacol 2000;58:82-88
25. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002;82: 1013-67
26. Ryu JK, McLarnon JG. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med 2008;13:2911-15
27. Rampe D, Wang L, Ringheim GE. P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J Neuroimmunol 2004;147:56-61
28. Skaper SD, Facci L, Culbert AA, et al. P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia 2006;54:234-42
29. Choi HB, Ryu JK, Kim SU, et al. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglia activation and neuronal damage in inflamed brain. J Neurosci 2007;27:4957-68
30. Gandelman M, Peluffo H, Beckman JS, et al. Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: Implications for amyotrophic lateral sclerosis. J Neuroinflamm 2010;7:33
31. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, et al. A tetrazolium-based colorimetric MTT assay to quantitate human monocyteYmediated cy-totoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 1994;174:311-20
32. Whittle IR, Macarthur DC, Malcolm GP, et al. Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumors. J Neurooncol 1998;36:231-42
33. Newton HB. Handbook of Brain Tumor Chemotherapy. 1st ed. San Diego, CA: Academic Press, 2005
34. Vogelbaum MA. Convection enhanced delivery for treating brain tumor and selected neurological disorders. Symposium review. J Neurooncol 2007;83:97-109
35. Grobben B, De Deyn PP, Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 2002;310:257-70
36. Remy M, Thaler S, Schumann RG, et al. An in vivo evaluation of brilliant blue G in animals and humans. Br J Ophthalmol 2008;92:1142-47